Chris is a partner and leads Deloitte’s US Advisory Life Sciences M&A practice. Chris has more than 20 years of experience with Deloitte and has experience in advising financial and strategic buyers and sellers on many aspects of acquisitions, including due diligence, accounting structuring, financial reporting, vendor due diligence, carve-outs and the preparation of pro forma financial statements. He has led domestic and global M&A teams on numerous acquisitions and divestiture transactions of varying sizes. Chris has significant experience in the life sciences and healthcare industry and has worked on transactions in the areas of pharmaceuticals, pharmaceutical distribution, medical devices/supplies, health information technology, physician practices, long-term care, home health managed care and durable medical equipment.
Chris presents at various industry and technical seminars sponsored by Deloitte and external organizations and has contributed to Deloitte-sponsored healthcare publications. He is a member of the American Institute of Certified Public Accountants, a member of the Illinois State CPA Society and formerly served on the Board of Directors for the Center for Healthcare Innovation.